mechanism for resistance of histoplasma capsulatum to fluconazole.

NLM AIDSLINE Mechanism for resistance of Histoplasma capsulatum to fluconazole. Wheat J; Vanden Bossche H; Marichal P; Indiana University School of
November 30, 1996

3rd Conf Retro and Opportun Infect. 1996 Jan 28-Feb 1;:157. Unique Fluconazole has been used for treatment of histoplasmosis in patients with AIDS but appears to be less effective than amphotericin B or itraconazole. Treatment failure or relapse occurred in nearly half of patients during a prospective trial (ACTG 174). The patient reviewed here improved initially but remained fungemic and subsequently relapsed. Isolates at week 8, 12 and 16 of therapy showed progressive increase in fluconazole MIC from 0.625 micrograms/ml initially to 20 micrograms/ml at relapse. Inhibition of ergosterol synthesis and accumulation of the sterol intermediaries obtusifolione and eburicol during incubation with fluconazole were reduced in the relapse isolate. The relapse isolate remained fully susceptible to itraconazole. These findings indicate that H. capssulatum may develop resistance to fluconazole and suggest that its 14 alpha-demethylase and/or ketosteroid reductase changed fluconazole treatment. Patients receiving fluconazole for histoplasmosis are at risk for failure because of development of resistance. Acquired Immunodeficiency Syndrome/COMPLICATIONS Antifungal Agents/PHARMACOLOGY/THERAPEUTIC USE Fluconazole/PHARMACOLOGY/THERAPEUTIC USE Histoplasma/DRUG EFFECTS/ENZYMOLOGY Histoplasmosis/COMPLICATIONS/*DRUG THERAPY Human Microbial Sensitivity Tests Treatment Failure ABSTRACT

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 COLORADO: Boulder Groups Honor More Than 150 Local AIDS Victims PENNSYLVANIA: Area Residents Screened for Hepatitis C on Sunday COLORADO: Peer to Peer: Teens Work to Educate Peers on Pregnancy, STDs at CCHS OREGON: Portland Barefoot 3 x 3 Benefit Tournament to Draw Hundreds to Northeast Portland TEXAS: Temple - Wellness and Sexual Health Classes Helping Kids to Abstain CONNECTICUT: Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C JAMAICA: AIDS Awareness Workshop Organised for High-School Students EUROPE: EU Issues Stringent Sharps Regulations CALIFORNIA: $50,000 Prisoner Prescription: Inmates Get Expensive Hepatitis C Treatment Tentative approval of lamivudine and tenofovir disoproxil fumarate Tablets, 300 mg/300 mg Quinn Faces Resistance: Gay Groups Have Endorsed Her, but Loud Faction Opposes City Council Speaker World Health Organization launches emergency response to antimalarial drug resistance GLOBAL: TB Prevention May Boost Drug Resistance, Study Finds Study: Widespread 'test-and-treat' HIV policies could increase dangerous drug resistance UNITED STATES: US Tuberculosis Rates Reach All-Time Low, But Resistance a Threat Antibiotic resistance a "catastrophic threat" - UK medical chief Kenya: Drug Resistance Risk As Displaced HIV Patients Skip ARV Doses CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Skin Cancer Therapies SWITZERLAND: Scientists Discover New Mechanism for Antibiotic Resistance SOUTH AFRICA: Recreational Use of HIV Drugs Leading to Pre-Treatment Resistance in South Africa
Information in this article was accurate in November 30, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.